Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.35 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | PRCP | P42785 | 1/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.35 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.35 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15528148 | 1.00 | CYP3A4 (0.35) | CYP3A4MAPK1MEN1CYP2D6ALOX15 | |
| SCHEMBL18048399 | 0.79 | CYP3A4 (0.37) | CYP3A4MAPK1MEN1CYP2D6ALOX15 | |
| SCHEMBL28302686 | 0.78 | CYP3A4 (0.41) | CYP3A4MAPK1MEN1CYP2D6ALOX15 | |
| SCHEMBL27763868 | 0.76 | LMNA (0.38) | — | |
| SCHEMBL28145473 | 0.73 | CYP3A4 (0.43) | CYP3A4MAPK1MEN1CYP2D6ALOX15 | |
| SCHEMBL28266761 | 0.70 | KMT2A (0.33) | KMT2A | |
| SCHEMBL30792983 | 0.69 | CYP3A4 (0.33) | CYP3A4MAPK1MEN1CYP2D6ALOX15 | |
| SCHEMBL21801631 | 0.68 | MAPK1 (0.53) | MAPK1SMN1; SMN2 | |
| SCHEMBL27937705 | 0.68 | MAOA (0.36) | CYP2D6CYP2C19TSHRNFKB1SMN1; SMN2 | |
| SCHEMBL30726174 | 0.67 | PDK2 (0.34) | MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220081407-A1 | METHODS OF PREPARING SUBSTITUTED INDANES | PELOTON THERAPEUTICS, INC. (US) | 2022-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220081407-A1 | METHODS OF PREPARING SUBSTITUTED INDANES | HIF1AN, EGLN2, HIF1A | CYP3A4 609/4885MAPK1 3060/4885MEN1 2565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.